Study: Randomized, double-blind phase III trial (ROBUST) Previously untreated ABC-type diffuse large B cell lymphoma CD20+, Stages II-IV, cell of origin identified using nCounter Dx R-CHOP + lenalidomide x 6
Study: Randomized, double-blind phase III trial (CheckMate 577) Esophageal or GE junction cancer (adeno or SCC) pts who received neoadjuvant chemoRT => undergone R0 resection during which pathological residual disease
Study: Single-arm, phase II trial (HORIZON) Multiple myeloma with >2 prior lines (including IMiD and proteasome inhibitor) and refractory to pomalidomide and/or anti-CD38 Ab Monthly melflufen + weekly dexamethasone until
Study: Randomized, double-blind phase II trial First-line for metastatic small cell carcinoma CARBOplatin-Etoposide-Atezolizumab backbone. Trilaciclib vs. placebo infused once daily prior to chemo on days 1-3 Efficacy: Mean duration of
Study: Open label, randomized phase II trial (SWOG 1500) Metastatic papillary renal cell Ca. No prior VEGF therapy Efficacy: Cabozantinib (n=44) vs. sunitinib (n=46) vs. crizotinib vs. savolitinib (latter two
Study: Phase II, open-label (Study 1620) Unresectable locally advanced or metastatic basal cell carcinoma progressed or no response to or intolerant to hedgehog pathway inhibitor therapy (N=112) Cemiplimab 350 q21
Study: Open-label, randomized phase II trial Metastatic colorectal cancer, refractory or intolerant to fluoropyrimidines, irinotecan, oxaliplatin, and anti-EGFR (for RAS WT) Trifluridine/tipiracil with (n=47) vs. without bevacizumab (n=46) Efficacy: Disease
Study: Open-label, randomized phase II trial (DESTINY-Gastric01) Her2-positive gastric/GE junction adenoCa pts who received >=2 previous regimens including 5-FU, platinum, and trastuzumab Trastuzumab deruxtecan (n= 125) vs. physician’s choice of
Study: Open-label, randomized phase III trial (ANDROMEDA) Newly diagnosed light chain amyloidosis with >=1 affected organ CyBorD with or without subQ daratumumab (n= 195 and 193, respectively) Efficacy: Hematologic CR:
Privacy & Cookies Policy
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.